ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Burn-X, magensaftresistente Tabletten - 14
68814012 axapharm ag
Burn-X, magensaftresistente Tabletten17.02.2022
  17.02.2022
Esomeprazole (A02BC05) 
WHO-DDD 
14
04.99. 
D  
No 
IPCI
PR  
k.A.PR
  
7680688140125Synthetika
  
Composition
esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, hypromellosum, sacchari sphaerae, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, povidonum, macrogolum 6000, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (flavum) pro compresso obducto corresp. natrium 0.082 mg.
Packungsbestandteile
Gastric juice resistant tablets
 
Active AgentDose
Esomeprazol20 mg
 
Inactive agentsDoseadditional_information
(Flavum) pro Compresso Obducto  
(Rubrum)  
Acidi Methacrylici  
Cellulosum Microcristallinum  
Crospovidonum  
E 171 color.
E 172 color.
Ethylis Acrylatis Polymerisatum  
Glyceroli Monostearas40-55 
Hydroxypropylcellulosum  
Hypromellosum Überzug
Macrogol400  
Magnesii Stearas  
Natrii Laurilsulfas  
Natrii Stearylis Fumaras  
Polysorbatum 80  
Povidone  
Sacchari Sphaerae  
Talcum  
Triethylis Citras  
Source
Data was imported : 14.04.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home